| NDC Code | 63479-0207-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, GLASS (63479-0207-1) |
|---|
| Product NDC | 63479-0207 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | B07 |
|---|
| Proprietary Name Suffix | Dprsn Antitox |
|---|
| Non-Proprietary Name | Adrenalinum, Aethusa Cynapium, Agnus Castus, Alfalfa, Argentum Nitricum, Aurum Metallicum, Avena Sativa, Ceratostigma Willmottianum Flower, Cherry Plum Flower, Damiana, European Aspen Flower, European Hornbeam Flower, Gorse Flower, Hypericum Perforatum, Kali Phosphoricum, Lycopodium Clavatum, Mandragora Officinarum, Natrum Muriaticum, Passiflora Incarnata, Rosa Canina Flower, Sepia, Sweet Chestnut Flower, Thyroidinum, Wild Mustard Flower |
|---|
| Dosage Form | SOLUTION/ DROPS |
|---|
| Usage | SUBLINGUAL |
|---|
| Start Marketing Date | 19970715 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Apex Energetics Inc. |
|---|
| Substance Name | CHASTE TREE; AVENA SATIVA FLOWERING TOP; CARPINUS BETULUS FLOWER; CASTANEA SATIVA FLOWER; THYROID, UNSPECIFIED; TURNERA DIFFUSA LEAFY TWIG; POPULUS TREMULA FLOWERING TOP; ULEX EUROPAEUS FLOWER; SODIUM CHLORIDE; PASSIFLORA INCARNATA FLOWERING TOP; SEPIA OFFICINALIS JUICE; GOLD; EPINEPHRINE; PRUNUS CERASIFERA FLOWER; HYPERICUM PERFORATUM; POTASSIUM PHOSPHATE, DIBASIC; MANDRAGORA OFFICINARUM ROOT; LYCOPODIUM CLAVATUM SPORE; ROSA CANINA FLOWER; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; AETHUSA CYNAPIUM; ALFALFA; SILVER NITRATE; CERATOSTIGMA WILLMOTTIANUM FLOWER |
|---|
| Strength | 30; 1; 1; 15; 15; 30; 2; 6; 30; 3; 60; 30; 1; 30; 30; 15; 15; 30; 30; 15; 30; 6; 1; 30 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
|---|